Abstract
A 51-year-old black woman with diabetes mellitus developed severe hepatotoxicity after receiving high-dose L-asparaginase (Elspar) for acute lymphatic leukemia. Patients with diabetes should be given this drug cautiously. Glutaminase-free L-asparaginase from Vibrio succinogenes has been reported to be less hepatotoxic in mice; it might be a safer product for this group of patients.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Distasio J. A., Salazar A. M., Nadji M., Durden D. L. Glutaminase-free asparaginase from vibrio succinogenes: an antilymphoma enzyme lacking hepatotoxicity. Int J Cancer. 1982 Sep 15;30(3):343–347. doi: 10.1002/ijc.2910300314. [DOI] [PubMed] [Google Scholar]
- Durden D. L., Salazar A. M., Distasio J. A. Kinetic analysis of hepatotoxicity associated with antineoplastic asparaginases. Cancer Res. 1983 Apr;43(4):1602–1605. [PubMed] [Google Scholar]
- Oettgen H. F., Stephenson P. A., Schwartz M. K., Leeper R. D., Tallai L., Tan C. C., Clarkson B. D., Golbey R. B., Krakoff I. H., Karnofsky D. A. Toxicity of E. coli L-asparaginase in man. Cancer. 1970 Feb;25(2):253–278. doi: 10.1002/1097-0142(197002)25:2<253::aid-cncr2820250204>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
- Pratt C. B., Johnson W. W. Duration and severity of fatty metamorphosis of the liver following L-asparaginase therapy. Cancer. 1971 Aug;28(2):361–364. doi: 10.1002/1097-0142(197108)28:2<361::aid-cncr2820280215>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
- Wade H. E., Phillips B. P. Automated determination of bacterial asparaginase and glutaminase. Anal Biochem. 1971 Nov;44(1):189–199. doi: 10.1016/0003-2697(71)90360-5. [DOI] [PubMed] [Google Scholar]